Invention Grant
- Patent Title: BCL-2 inhibitors
-
Application No.: US16045736Application Date: 2018-07-26
-
Publication No.: US10377755B2Publication Date: 2019-08-13
- Inventor: Yi Chen , Yan Lou
- Applicant: Newave Pharmaceutical Inc.
- Applicant Address: US CA Pleasanton
- Assignee: Newave Pharmaceutical Inc.
- Current Assignee: Newave Pharmaceutical Inc.
- Current Assignee Address: US CA Pleasanton
- Agency: McCarter & English, LLP
- Agent Yu Lu; Wei Song
- Main IPC: C07D471/14
- IPC: C07D471/14 ; A61P35/02 ; A61P35/00
Abstract:
The disclosure includes compounds of Formula (I) wherein W, R1, R2, R3, R4, R5, R6, m, n, L, and Z1, are defined herein. Also disclosed is a method for treating a neoplastic disease and autoimmune disease with these compounds.
Public/Granted literature
- US20190040062A1 BCL-2 INHIBITORS Public/Granted day:2019-02-07
Information query
